Immunogenicity and safety of a live attenuated varicella vaccine in children 1-12 years of age: A randomized, blinded, controlled, non-inferiority phase 3 clinical trial
Jiang, F; Zhang, RZ; Guan, QH; Mu, QY; He, P; Ye, XG; Wang, WJ; Quan, JD; Li, JQ; Liang, LX; Zeng, FX; Tang, N; Xu, F; Wu, P; Pan, YY; Yu, XY; Yu, XQ; Zheng, LC; Zhao, Y; Cai, MY; Li, C; Zhong, Y; Cao, XH; Yu, Y; Zhang, XY; Zhang, T; Wang, PY; Lei, SG
Lei, SG (corresponding author), Guizhou Prov Ctr Dis Control & Prevent, Inst Expanded Programme Immunizat, Guiyang 550004, Guizhou, Peoples R China.; Wang, PY (corresponding author), Shanghai Rongsheng Biotech Co Ltd, Shanghai, Peoples R China.; Zhang, T (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.; Zhang, T (corresponding author), Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China.
CONTEMPORARY CLINICAL TRIALS, 2021; 107 ():
